John Ramunas
CEO and co-founder of Rejuvenation Technologies Inc
Invented the first safe telomere extension drug, TERT mRNA, patented by Stanford. Invented the simplest pump, patented by Stanford. Co-founded Rejuvenation Technologies to make TERT mRNA-based telomere extension available as broadly and quickly as possible. Experienced founder with a demonstrated history of success, experienced in programming, molecular biology, stem cell biology, animal models, management, mentoring, and drug development. 3 patents, 14 publications, in PNAS, Nature Molecular Therapy, Sensors and Actuators, others.
Visit website: https://rejuvenationtech.com/Team/
See also: Rejuvenation Technologies - Biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres
Details last updated 04-Sep-2020
John Ramunas News
Rejuvenation Technologies raises $10.6M to develop anti-ageing therapies
Longevity Technology - 07-Sep-2023
A single dose of mRNA therapy could rewind ageing and extend lifespan
Read more...Telomere extension turns back aging clock in cultured human cells
Stanford University - 22-Jan-2015
Researchers delivered a modified RNA that encodes a telomere-extending protein to cultured human ...
Read more...